Pharmaceuticals

Global Anti-Thyroid Drugs Market Trends and Growth Analysis 2025–2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Anti-Thyroid Drugs Market Expected To Expand Between 2025 And 2029?

The anti-thyroid drugs market size has seen modest growth in recent years. This market is projected to expand from $2.46 billion in 2024 to $2.49 billion by 2025, reflecting a compound annual growth rate (CAGR) of 1.2%. The historical increase in the market can be attributed to the prevalence of thyroid disorders, advancements in drug development, and improvements in healthcare infrastructure.

The anti-thyroid drugs market size is projected to experience consistent expansion over the upcoming years. By 2029, this market is anticipated to reach $2.76 billion, exhibiting a compound annual growth rate (CAGR) of 2.6%. Several factors are expected to drive this growth during the forecast period, including increased patient awareness and education, rising healthcare expenditure, evolving patient demographics, and prevailing global economic conditions. Key trends identified for the forecast period encompass alternatives to thyroid surgery and radioactive iodine, a shift towards patient-centric care, and the integration of telemedicine and remote monitoring.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which Major Market Drivers Are Shaping The Future Of The Anti-Thyroid Drugs Market?

Graves’ disease is a direct contributor to hyperthyroidism, and its incidence is on the rise. According to the National Library of Medicine, a US-based biomedical library operated by the United States federal government, Graves’ disease (GD) is the most frequent cause of hyperthyroidism in developed countries. It primarily affects individuals between 30 and 60 years of age, and women are 5–10 times more prone to it than men. Genetic predisposition accounts for 79% of the risk for GD, while environmental factors are responsible for 21%. Due to the increasing number of Graves’ disease cases, the population suffering from hyperthyroidism is also expanding. This trend subsequently leads to an overall increase in the demand for anti-thyroid drugs, thereby driving the market forward.

What Are The Leading Segments Analyzed In The Anti-Thyroid Drugs Market?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

How Are Trends Influencing The Anti-Thyroid Drugs Market?

Associations for thyroid care are launching initiatives to broaden understanding of thyroid disorders, share recent treatment advancements, and provide overviews of various research conducted on thyroid conditions. A concerning issue is that in the USA, nearly 60% of the population with hyperthyroidism is unaware and goes undiagnosed. To mitigate these problems, organizations like the American Thyroid Association (ATA) are actively educating people about thyroid disorders. Similarly, the Thyroid Foundation of Canada has also undertaken awareness campaigns to engage public interest and knowledge about thyroid diseases, including hyperthyroidism. Other groups initiating awareness programs include the American Academy of Otolaryngology and the British Thyroid Foundation, among others.

Which Major Industry Participants Are Leading The Anti-Thyroid Drugs Market Growth?

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Which Geographies Are Emerging As Strong Markets For The Anti-Thyroid Drugs Industry?

North America was the largest region in the anti-thyroid drugs market in 2024. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Anti-Thyroid Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp

Browse Through More Reports Similar to the Global Anti-Thyroid Drugs Market 2025, By The Business Research Company

Diuretics Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

Genito Urinary Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795